Understanding how molecules interact is central to biology: from decoding how living organisms function to uncovering disease ...

Over the past year, drug discovery has gotten a massive boost from the CAS BioFinder Discovery Platform, which allows ...

The BioAssemblyBot ® 400 (BAB400) was utilized to automate CRC dome assays, allowing for standardized processing and uniform ...

In the past, most targeted drug development efforts relied on single biomarkers, but cancer is far more complex. BostonGene’s ...

RenaissThera is filing 'Composition of Matter' and utility patents for these oral novel small molecule GIPR modulators and continues to expand its innovation portfolio targeting GIP, GLP-1, and apelin ...

The MIT model predicts molecular binding affinity at newfound speed and accuracy, offering a powerful tool for commercial drug discovery.

KQ Labs has supported 70 startups, which have raised over £219 million in investment. Applications for the next program open ...

The integration of Ro5's AI drug discovery platform and expert team into Juvenescence will accelerate the identification and development of AI-enabled therapeutics, reinforcing the company's growing ...

Bringing a new drug to market can take about 10 years, but artificial intelligence may soon change that, said Phil Mounteney, ...

Insilico Medicine, the biotech company with twin headquarters in Boston and Hong Kong, said it’s the first time an AI-created ...

Insilico Medicine said results of a clinical trial in China showed positive results in treating idiopathic pulmonary fibrosis ...

Recursion Pharmaceuticals and Schrodinger leverage their respective AI drug discovery platforms to potentially develop distinguished therapeutic candidates.